Life Sciences

The aim is to offer a broader range of personalized treatment options to patients.

The aim of the partnership is to research how AI can help predict cancer progression.

After a clinician prescribes a medication, Connect sends the patient a text message with a link to pharmacies offering the lowest price for the drug.

The company will use the funds to enhance the development of its AI capabilities and for commercial growth.  

Vitalchat also garnered $6 million in a Series A round, and Cerula Care secured $3.7 million in an oversubscribed seed funding round.

The alliance will result in the integration of Kyruus Health's care access platform with aha!'s "low-code/no-code" health experience platform.   

Kauvery Hospital invests in Lifesigns Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.  The new funds, based on a press statement, will "advance Lifesigns’ AI and predictive algorithm capabilities." The company offers an AI-powered remote patient monitoring system that provides alerts and predictive insights.   Lifesigns is now gearing for its next fundraising, where it plans to launch a new product and introduce expansion initiatives.  AI-powered sleep apnoea app now prescribed at major Korean hospital Seoul National University Bundang Hospital is the first among hospitals in South Korea to prescribe an AI-powered mobile application for diagnosing sleep apnoea.  The diagnostic support tool called Apnotrack by medical AI company Asleep records a user's breathing and then uses AI to assess for sleep apnoea.  Asleep claims its app to have comparable performance with at-home polysomnography tests.  Apnotrack received an innovative medical device designation from the South Korean government in 2023 and was approved as a Class II medical device by the Ministry of Food and Drug Safety last year.  TriNetX launches JV with Fujitsu in Japan Global health research network TriNetX has partnered with Fujitsu to launch a joint venture in Japan. The JV, according to a press release, will provide healthcare researchers and pharmaceutical companies in Japan with secure access to big medical and health datasets.  TriNetX runs a self-service data exploration platform for clinical researchers, featuring over 200 million patient records. Its integration with Fujitsu's cloud-based healthcare platform will "create an environment where Japanese medical data, previously underutilised, can be efficiently leveraged for clinical research," said Tatsuki Araki, head of Fujitsu's Healthy Living division.

The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.

Everly Health Solutions alleged that Walgreens broke the terms of a 2020 business contract during the COVID-19 pandemic.   

The aim of Conduent's Maven is to help epidemiologists detect, monitor, track and report health threats.